82265-53-0

Upstream product

• 15761-39-4 1-(tert-butoxycarbonyl)-L-proline 
• 66876-51-5 {(S)-2-[2-((S)-2-Amino-3-phenyl-propionylamino)-acetylamino]-3-phenyl-propionylamino}-acetic acid methyl ester; hydrochloride 

Downstream Products

• 82265-54-1 (S)-2-[(S)-1-({[(S)-1-(Hydrazinocarbonylmethyl-carbamoyl)-2-phenyl-ethylcarbamoyl]-methyl}-carbamoyl)-2-phenyl-ethylcarbamoyl]-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 82247-66-3 [(S)-3-Phenyl-2-(2-{(S)-3-phenyl-2-[((S)-pyrrolidine-2-carbonyl)-amino]-propionylamino}-acetylamino)-propionylamino]-acetic acid methyl ester; hydrochloride 
• 82247-65-2 (S)-Pyrrolidine-2-carboxylic acid [(S)-1-({[(S)-1-(hydrazinocarbonylmethyl-carbamoyl)-2-phenyl-ethylcarbamoyl]-methyl}-carbamoyl)-2-phenyl-ethyl]-amide; hydrochloride 

Relevant academic research and scientific papers

Peptide Conformations. 15. One- and Two-Dimensional 1H, 13C, and 15N NMR Studies of cyclo(Pro-Phe-Gly-Phe-Gly)n (n = 1,2): Selective Complexation of Lithium Ions (n = 1) and Potassium Ions (n = 2)

The cyclic pentapeptide cyclo(Pro-Phe-Gly-Phe-Gly) (1), the cyclic decapeptide with dimer sequence 2, and four specifically deuterated derivatives were synthesized and studied by NMR spectroscopy.Two-dimensional correlation techniques, such as SECSY spect